Assay Validation
Selectivity HPLC peaks of HSYA and rutin were identified on the basis of their retention times and UV spectra obtained from diode-array UV detector. Samples from drug-free rats or beagle dogs were tested for the presence of endogenous compounds co-eluting with HSYA and rutin.
Recovery, stability and limit of quantitation (LOQ)
Recoveries of HSYA were determined by comparison of peak areas obtained after injection of extracted QC samples and corresponding standard solutions (n = 6). For the stability studies of HSYA after rat and dog plasma sample preparation, low, medium and high QC samples were placed at room temperature for 6 h and 12 h and then quantified (n = 6). The freeze-thaw stability in rat and dog plasma was evaluated by analyzing low, medium and high QC samples after undergoing three plasma freeze ( 40°C)-thaw (room temperature) cycles (n = 3). The storage stabilities of HSYA and rutin in working solutions at 4 °C were evaluated by direct injection of the solutions (400 mg/L of HSYA and 300 mg/L of rutin, n = 2) every week for one month. The LOQ of HSYA was calculated as the minimum concentration that could be quantified with no more than 15% relative standard deviation (R.S.D.) and 15% absolute values of relative error (R.E.).
Linearity
Calibration standards were subjected to extraction and HPLC analysis in triplicate.
Quantitation of HSYA was based on calibration curves of peak area ratio (drug/internal standard) versus concentration. Linearity was assessed by linear regression analysis with a weighting factor of 1/c 2 (c is the experimental plasma concentration). HSYA at 3 mg/kg (G), a rat feces sample 24 h after an intravenous injection of HSYA at 3 mg/kg (H), and a rat bile sample 6 h after an intravenous injection of HSYA at 3 mg/kg (I).
Chromatographic peaks labeled I and II are HSYA and rutin. 
